High-performance liquid chromatographic determination of prostacyclin

Area of Science:

• Analytical Chemistry
• Biochemistry

Background:

• Prostacyclin (PGI2) is a vital eicosanoid with significant physiological roles.
• Accurate quantification of prostacyclin and its metabolites is crucial for research and diagnostics.
• Existing analytical methods may lack the required specificity or sensitivity for complex biological samples.

Purpose of the Study:

• To develop and validate a high-performance liquid chromatographic (HPLC) method for the precise analysis of prostacyclin.
• To achieve robust separation of prostacyclin from its degradation products and related prostaglandins.
• To establish a sensitive method for impurity profiling.

Main Methods:

• Development of a reversed-phase HPLC column packing.
• Optimization of chromatographic conditions for prostacyclin separation.
• Validation of the method using replicate injections and impurity analysis.

Main Results:

• The developed HPLC method demonstrated high performance with a relative standard deviation of less than 1% for prostacyclin analysis.
• The system effectively resolved prostacyclin from its primary hydrolysis product, 6-oxo-prostaglandin F1 alpha.
• Impurities, including other prostaglandins, could be quantified at levels as low as approximately 0.5%.

Conclusions:

• The described laboratory-prepared reversed-phase HPLC method provides a reliable and sensitive approach for prostacyclin quantification.
• This method is suitable for distinguishing prostacyclin from related compounds and assessing purity.
• The technique shows potential for analyzing other prostaglandins as well.